Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1Classical hematology 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 226Lymphoma 221Lymphoma, Non-Hodgkin 194Leukemia, Lymphocytic, Chronic, B-Cell 175Lymphoma, Large B-Cell, Diffuse 170Lymphoma, Follicular 164Lymphoma, B-Cell 108Lymphoma, Mantle-Cell 102Hodgkin Disease 99Recurrence 94Leukemia, Myeloid, Acute 94Multiple Myeloma 89Burkitt Lymphoma 86Leukemia 76Neoplasms 66Hematologic Neoplasms 58Lymphoma, B-Cell, Marginal Zone 56Myelodysplastic Syndromes 52Waldenstrom Macroglobulinemia 42Lymphoma, T-Cell 42Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 37Lymphoma, T-Cell, Peripheral 35Lymphoma, T-Cell, Cutaneous 31Leukemia, Biphenotypic, Acute 28Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27Leukemia, B-Cell 27Mycosis Fungoides 25Lymphoma, Large-Cell, Anaplastic 25Sarcoma 24Lymphoproliferative Disorders 20

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Influenza, Human × Lymphoid × 90 days × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡